Bel­gian up­start Rewind taps Ian Reynolds as CEO; Robert Fos­ter takes the reins at Con­traVir

→ With $17 mil­lion of Se­ries A mon­ey in tow, Bel­gian biotech Rewind Ther­a­peu­tics has found a new leader in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.